Function indications, usage and dosage, notice of 91 varieties
-
Last Update: 2019-09-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Our commission now publicizes the relevant medical contents of the new and revised varieties in the first part of the Chinese Pharmacopoeia (2020 version) (see the appendix for details) The publicity period is one month If you have any comments or suggestions, please send them back to our committee The official seal shall be affixed to the letter, and the receiving unit shall be the office of the national pharmacopoeia commission If no reply is made within the publicity period, it shall be deemed that there is no objection to the draft publicity standard Tel.: (010) 67079567 received by: Office of the national pharmacopoeia committee address: building 11, fahanli, Dongcheng District, Beijing postcode: 100061 Annex: publicity draft of new and revised varieties of medical contents of the first part of Chinese pharmacopoeia in 2020 version.pdf National Pharmacopoeia Committee September 23, 2019
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
